New research highlights persistent gender disparities in medical treatment, revealing that women with the same health conditions as men are less likely to receive appropriate active care. This gap exists across a range of medical fields—including kidney, heart, and liver diseases—beyond the traditionally gendered specialties such as gynecology.

Experts emphasize that women experience 50% to 70% more adverse drug reactions than men, yet remain underrepresented in clinical trials. Historical exclusion policies aimed at protecting pregnant women, combined with practical challenges like balancing family and work responsibilities, contribute to this underrepresentation. Without adequate female participation in clinical studies, medications and treatment protocols may fail to address sex-specific physiological differences, prolonging health inequalities.

A British Heart Foundation-funded study found that women are less likely to be given recommended care following heart attacks, a disparity associated with significant mortality. Research from 2018 estimated that more than 8,000 women’s deaths in the U.K. over a decade could have been prevented had they received the same treatment as men.

Medical professionals cite “medical misogyny” as a systemic issue that extends beyond conditions traditionally considered “women’s problems.” This bias results in women receiving fewer diagnostic investigations and less effective care for serious illnesses.

Calls for systemic change advocate for mandatory education on women’s health and sex- and gender-sensitive medicine throughout healthcare training and continuing professional development. Early education on sex and health in schools is also suggested to challenge stereotypes and improve understanding of women's health needs from a young age.

In some cases, patients have found relief only after seeking care from specialists attuned to women’s specific health concerns. For example, a patient with chronic pelvic pain reported significant improvement after receiving physiotherapy tailored to women’s health—an approach still not widely offered or recognized.

The forthcoming ten-year health plan and renewed women’s health strategy in England provide opportunities to address these disparities. Advocates stress that women are not seeking preferential treatment but rather equal access to timely diagnosis, appropriate investigations, and effective interventions.

With mounting evidence of unequal treatment adversely affecting women’s health outcomes, experts urge the medical community and policymakers to implement comprehensive measures aimed at closing the gender gap in healthcare delivery.